Fig. 8
From: SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer
The results of multi-omics analysis of SLC26A4. A Correlations between SLC26A4 expression and abundances of immune cells, including CD4 naïve T cell, exhausted T cell, Th1, and Th2 cell. B Kaplan–Meier survival plots of SLC26A4 in TCGA-PRAD, MSKCC, and GSE116918 cohorts. C Forest plot of meta-analysis integrating SLC26A4’s role in these three datasets. D Expression levels of SLC26A4 between normal and tumor tissues in pan-cancer. E Correlations between SLC26A4 and survival in pan-cancer. F Correlations between SLC26A4 expression and functional states at the single-cell level. G Correlations between SLC26A4 expression and methylation. The statistical significance is indicated as asterisks (*), *p < 0.05, ** p < 0.01, ***p < 0.001, ns: not significant